Literature DB >> 1127970

The surgical anatomy of pulmonary atresia with ventricular septal defect: pseudotruncus.

S Bharati, M H Paul, F S Idriss, R T Potkin, M Lev.   

Abstract

This is a study of 172 heart specimens with pulmonary atresia and ventricular septal defect (VSD)--pseudotruncus. These are divided into simple and complicated types. In the simple type the following may be of importance from the surgical standpoint: (1) the size of the pulmonary arteries, (2) the origin of the aorta, (3) the amount of pulmonary flow, (4) the size of the left side of the heart, (5) the presence of bronchial and/or abnormal systemic supply to the lungs, (6) the coronary circulation, and (7) the presence of intra- and extracardiac associated abnormalities. The following factors may be important in the complicated types: (1) Complete transposition may accompany the complex; (2) instead of the VSD there may be a common atrioventricular (AV) orifice; (3) the pulmonary atresia with VSD may be associated with tricuspid or mitral atresia or with common or single ventricle; (4) the entity may be associated with abnormal position of the entire heart or some of its component chambers.

Entities:  

Mesh:

Year:  1975        PMID: 1127970

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  Successful repair of pulmonary atresia with ventricular septal defect without the use of a conduit: a new surgical option. Report of two cases.

Authors:  Z al-Halees; O Galal; N Wilson
Journal:  Br Heart J       Date:  1992-09

2.  Pulmonary atresia with ventricular septal defect. Further anatomical observations.

Authors:  G Thiene; U Bortolotti; V Gallucci; M L Valente; S D Volta
Journal:  Br Heart J       Date:  1977-11

3.  Angiographic evidence of absent ductus arteriosus in severe right ventricular outflow obstruction.

Authors:  S J Lacina; W T Hamilton; O G Thilenius; S Bharati; M Lev; R A Arcilla
Journal:  Pediatr Cardiol       Date:  1983 Jan-Mar       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.